UFP Technologies’ second quarter was marked by robust growth in its medical segment, which management credited as the primary driver of overall sales gains. CEO R. Jeffrey Bailly highlighted that the company’s medical business expanded 46%, with notable contributions from robotic-assisted surgery and wound care. Management attributed the positive market reaction to strong execution despite operational hurdles, specifically referencing the labor turnover at the AJR facility. Bailly explained, “Although that process is complete, it has and will continue to have an impact on labor efficiency and revenue at that location as new legally eligible employees slowly increase their output with additional training and experience.”

Is now the time to buy UFPT? Find out in our full research report (it’s free).

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions From UFP Technologies’s Q2 Earnings Call

• Brett Fishbin (KeyBanc Capital Markets) asked about the breadth of opportunity in robotic-assisted surgery. CEO R. Jeffrey Bailly emphasized strong fit with customer needs and long-term growth from both established and developing customers.
• Fishbin (KeyBanc Capital Markets) also probed AJR’s inorganic revenue trends. Bailly clarified that labor inefficiency at AJR was the main cause of sequential revenue decline, with other acquisitions performing to plan.
• Jaeson Schmidt (Lake Street) inquired about channel inventory normalization. Bailly responded that inventory destocking appears complete, with strong growth across markets and inventory at AJR customers now quite low.
• Justin Ages (CJS Securities) questioned market share in drape production. Bailly stated the company’s share is steady at about two-thirds, supported by reliable customer forecasting.
• Andrew Cooper (Raymond James) asked about margin outlook amid labor and tariff issues. CFO Ronald Lataille projected margin pressure in Q3, but expected a rebound in Q4 as labor disruptions subside.

Catalysts in Upcoming Quarters

In future quarters, the StockStory team will be monitoring (1) the pace of labor recovery and operational output at the AJR facility, (2) the successful ramp of new program launches and expansions in the Dominican Republic, and (3) the effectiveness of integrating UNIPEC and Techno Plastics Industries to drive synergies. Progress on these fronts will help determine if UFP Technologies can sustain its recent growth trajectory while improving profitability.

UFP Technologies currently trades at $220.50, down from $226.18 just before the earnings. At this price, is it a buy or sell? Find out in our full research report (it’s free).

Our Favorite Stocks Right Now

When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.

Don’t let fear keep you from great opportunities and take a look at Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.

StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.